Literature DB >> 21561416

Rho GTPase effector functions in tumor cell invasion and metastasis.

Somesh Baranwal1, Suresh K Alahari.   

Abstract

Rho GTPases (Ras homologous family) comprise the largest subfamily cluster of the Ras-homology superfamily. Rho GTPases exist in inactive GDP and active GTP forms. The active forms of the Rho family members bind with numerous effector proteins that are crucial for various biological processes. Accumulating evidence exemplifies the importance of Rho effector proteins in various steps of cancer progression. Here, we highlight the actions of various effectors of Rho members in cancer invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21561416     DOI: 10.2174/138945011795906534

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  16 in total

Review 1.  Rho-kinase: regulation, (dys)function, and inhibition.

Authors:  Ehsan Amin; Badri Nath Dubey; Si-Cai Zhang; Lothar Gremer; Radovan Dvorsky; Jens M Moll; Mohamed S Taha; Luitgard Nagel-Steger; Roland P Piekorz; Avril V Somlyo; Mohammad R Ahmadian
Journal:  Biol Chem       Date:  2013-11       Impact factor: 3.915

2.  Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase.

Authors:  Brenda L Montalvo-Ortiz; Linette Castillo-Pichardo; Eliud Hernández; Tessa Humphries-Bickley; Alina De la Mota-Peynado; Luis A Cubano; Cornelis P Vlaar; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

Review 3.  Small-molecule SMAC mimetics as new cancer therapeutics.

Authors:  Longchuan Bai; David C Smith; Shaomeng Wang
Journal:  Pharmacol Ther       Date:  2014-05-16       Impact factor: 12.310

4.  TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance.

Authors:  Joseph C Loftus; Harshil Dhruv; Serdar Tuncali; Jean Kloss; Zhongbo Yang; Cassie A Schumacher; Brian Cao; Bart O Williams; Jennifer M Eschbacher; Julianna T D Ross; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2013-05-22       Impact factor: 5.852

5.  CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth.

Authors:  Tai Young Kim; Sarah Jackson; Yue Xiong; Timothy G Whitsett; Janine R Lobello; Glen J Weiss; Nhan Le Tran; Yung-Jue Bang; Channing J Der
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

6.  Triptolide inhibits proliferation and invasion of malignant glioma cells.

Authors:  Haipeng Zhang; Wenbo Zhu; Xingwen Su; Sihan Wu; Yuan Lin; Jingjie Li; Youqiong Wang; Jingkao Chen; Yuxi Zhou; Pengxin Qiu; Guangmei Yan; Shujin Zhao; Jun Hu; Jingxia Zhang
Journal:  J Neurooncol       Date:  2012-05-05       Impact factor: 4.130

7.  KDM6A-ARHGDIB axis blocks metastasis of bladder cancer by inhibiting Rac1.

Authors:  Lei Liu; Jianfeng Cui; Yajing Zhao; Xiaochen Liu; Lipeng Chen; Yangyang Xia; Yong Wang; Shouzhen Chen; Shuna Sun; Benkang Shi; Yongxin Zou
Journal:  Mol Cancer       Date:  2021-05-18       Impact factor: 27.401

8.  B3GNT3 acts as a carcinogenic factor in endometrial cancer via facilitating cell growth, invasion and migration through regulating RhoA/RAC1 pathway-associated markers.

Authors:  Ji-Shui Wang; Fang Ruan; Li-Zhu Guo; Feng-Ge Wang; Fu-Ling Wang; Hong-Min An
Journal:  Genes Genomics       Date:  2021-03-08       Impact factor: 1.839

Review 9.  Roles of rho GTPases in intracellular transport and cellular transformation.

Authors:  Xiaojuan Chi; Song Wang; Yifan Huang; Mark Stamnes; Ji-Long Chen
Journal:  Int J Mol Sci       Date:  2013-03-28       Impact factor: 5.923

10.  Overexpression of Ras homologous C (RhoC) induces malignant transformation of hepatocytes in vitro and in nude mouse xenografts.

Authors:  Shuli Xie; Mingguang Zhu; Guoyue Lv; Yajun Geng; Guofu Chen; Jian Ma; Guangyi Wang
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.